Published in Biochemistry on March 07, 1995
Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles. Protein Sci (2001) 0.87
Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci (1998) 0.81
Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains. Protein Sci (1998) 0.77
Validation of a new restraint docking method for solution structure determinations of protein-ligand complexes. J Biomol NMR (1999) 0.77
Molecular modelling, docking and interaction studies of human-plasmogen and salmonella enolase with enolase inhibitors. Bioinformation (2012) 0.75
Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science (1991) 3.24
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci U S A (1991) 2.43
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry (2007) 2.30
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol (2000) 2.25
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Earthworm bioluminescence: characterization of high specific activity Diplocardia longa luciferase and the reaction it catalyzes. Biochemistry (1981) 1.62
Siderochromes from Pseudomonas fluorescens. I. Isolation and characterization. J Biol Chem (1982) 1.59
High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology (N Y) (1992) 1.43
Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry (2006) 1.43
Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat Struct Biol (2001) 1.43
The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. J Biol Chem (1990) 1.43
Engineered antibodies with increased activity to recruit complement. J Immunol (2001) 1.40
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry (2000) 1.34
Siderochromes from Pseudomonas fluorescens. II. Structural homology as revealed by NMR spectroscopy. J Biol Chem (1982) 1.30
Solution conformation of ferrichrome, a microbial iron transport cyclohexapeptide, as deduced by high resolution proton magnetic resonance. J Mol Biol (1970) 1.29
Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J Mol Biol (1993) 1.22
Dimerization of human growth hormone by zinc. Science (1991) 1.16
Solution structure of the E-domain of staphylococcal protein A. Biochemistry (1996) 1.12
Proton magnetic resonance study of crambin, a hyperstable hydrophobic protein, at 250 and 600 MHz. Biochemistry (1980) 1.10
ABACUS, a direct method for protein NMR structure computation via assembly of fragments. Proteins (2005) 1.10
Actin phylogeny identifies Mesostigma viride as a flagellate ancestor of the land plants. J Mol Evol (1998) 1.09
Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry (1994) 1.08
Effect of metal binding on the conformation of enterobactin. A proton and carbon-13 nuclear magnetic resonance study. Biochemistry (1973) 1.08
Contribution to global protein stabilization of the N-capping box in human growth hormone. Biochemistry (1994) 1.07
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
Equilibrium and kinetic measurements of the conformational transition of reduced thioredoxin. Biochemistry (1987) 1.05
Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry (1996) 1.04
Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments. Biochemistry (1990) 1.02
The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH. Br J Pharmacol (2012) 1.02
The second type II module from human matrix metalloproteinase 2: structure, function and dynamics. Structure (1999) 1.00
Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor. Protein Sci (1998) 1.00
The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry (2000) 0.99
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry (1999) 0.99
Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry (1992) 0.99
The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites. J Mol Biol (2001) 0.97
Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain. Protein Sci (1999) 0.97
Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci (1998) 0.97
Fab assembly and enrichment in a monovalent phage display system. Biotechnology (N Y) (1991) 0.96
Contribution of domain interface residues to the stability of antibody CH3 domain homodimers. Biochemistry (1998) 0.96
Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct. J Biol Chem (2001) 0.96
Conformational transitions of thioredoxin in guanidine hydrochloride. Biochemistry (1984) 0.95
The solution conformation of the ferrichromes. V. The hydrogen exchange kinetics of ferrichrome analogues; the conformational state of the peptides. J Biol Chem (1973) 0.93
Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin. Proteins (1988) 0.93
Domain organization of the 39-kDa receptor-associated protein. J Biol Chem (1999) 0.93
Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy. J Biol Chem (1990) 0.92
Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
The molecular basis for growth hormone-receptor interactions. Recent Prog Horm Res (1993) 0.91
Nitrogen-15 nuclear magnetic resonance spectrum of alumichrome. Detection by a double resonance Fourier transform technique. J Am Chem Soc (1976) 0.91
Amide proton spin-lattice relaxation in polypeptides. A field-dependence study of the proton and nitrogen dipolar interactions in alumichrome. Biophys J (1978) 0.90
Heparin binding to the urokinase kringle domain. Biochemistry (1992) 0.90
The tissue factor region that interacts with factor Xa in the activation of factor VII. Biochemistry (2001) 0.90
Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury. Gene Ther (2011) 0.89
Conformational changes in the reversed phase liquid chromatography of recombinant human growth hormone as a function of organic solvent: the molten globule state. Anal Chem (1994) 0.89
The two polypeptide chains in fibronectin are joined in antiparallel fashion: NMR structural characterization. Biochemistry (1992) 0.89
Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies. Thromb Haemost (2000) 0.89
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun (1998) 0.88
Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli. Biochemistry (1989) 0.88
Effects of guanidine hydrochloride on the refolding kinetics of denatured thioredoxin. Biochemistry (1986) 0.87
Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. J Mol Biol (1992) 0.87
Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles. Protein Sci (2001) 0.87
Protonated amino acid precursor studies on rhodotorulic acid biosynthesis in deuterium oxide media. Biochemistry (1972) 0.87
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. Biochemistry (1992) 0.86
Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal antibody IDEC-C2B8 after papain digestion. J Pharm Biomed Anal (1997) 0.86
Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J Mol Biol (1991) 0.86
Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR. Biochemistry (1997) 0.85
Identification of a GDP-L-fucose:polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology (1996) 0.84
A carbon-13 spin lattice relaxation study of alumichrome at 25.1 MHz and 90.5 MHz. Biochim Biophys Acta (1977) 0.84
15N nuclear magnetic resonance of living cells. Nature (1975) 0.84
Sequence-specific 1H NMR assignments and structural characterization of bovine seminal fluid protein PDC-109 domain b. Biochemistry (1991) 0.84
Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4. Chem Phys Lipids (1994) 0.83
Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen. Biochim Biophys Acta (1987) 0.83
Solution conformation of the ferrichromes. A comparative proton magnetic resonance study of glycine- and serine-containing ferrichromes. J Mol Biol (1972) 0.83
Peptide hydrogen bonding. Conformation dependence of the carbonyl carbon-13 nuclear magnetic resonance chemical shifts in ferrichrome. A study by 13C-[15N] Fourier double resonance spectroscopy1a. J Am Chem Soc (1977) 0.82
Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids. Biochemistry (1991) 0.82
The structure of two alanine containing ferrichromes: sequence determination by proton magnetic resonance. Biophys Struct Mech (1976) 0.82
Ligand specificity of human plasminogen kringle 4. Biochemistry (1991) 0.82
Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1. Eur J Biochem (1994) 0.82
Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity. Biochemistry (1999) 0.82
Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site. Biochemistry (1987) 0.81
Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains. Biochemistry (1996) 0.81
A nitrogen-15 spin-lattice relaxation study of alumichrome. Biochim Biophys Acta (1978) 0.81
Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage. Biochemistry (1994) 0.81
Peptide strain. Conformation dependence of the carbon-13 nuclear magnetic resonance chemical shifts in the ferrichromes. J Am Chem Soc (1977) 0.81
The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Biochemistry (1999) 0.81
Exploring functional genomics for drug target and therapeutics discovery in Plasmodia. Acta Trop (2007) 0.80
The solution conformation of the ferrichromes. IV. pH dependence of the individual slow amide hydrogen-deuterium exchange in alumichrome. J Biol Chem (1973) 0.80
Proton magnetic resonance characterization of phoratoxins and homologous proteins related to crambin. Biochemistry (1987) 0.79
1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4. Biochemistry (1989) 0.79
Solution structure of the kringle domain from urokinase-type plasminogen activator. J Mol Biol (1994) 0.79
Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site. J Mol Biol (1987) 0.79
Proton Overhauser experiments on kringle 4 from human plasminogen. Implications for the structure of the kringles' hydrophobic core. Biochim Biophys Acta (1985) 0.79
Inhibition of tumor growth by plasminogen-related protein-B. Anticancer Res (2001) 0.78